Next-generation sequencing for HLA typing of class I loci
- Rachel L Erlich†1,
- Xiaoming Jia†1, 2,
- Scott Anderson1,
- Eric Banks1,
- Xiaojiang Gao3, 4,
- Mary Carrington3, 4,
- Namrata Gupta1,
- Mark A DePristo1,
- Matthew R Henn1,
- Niall J Lennon1 and
- Paul IW de Bakker1, 5, 6, 7Email author
© Erlich et al; licensee BioMed Central Ltd. 2011
Received: 11 August 2010
Accepted: 18 January 2011
Published: 18 January 2011
Comprehensive sequence characterization across the MHC is important for successful organ transplantation and genetic association studies. To this end, we have developed an automated sample preparation, molecular barcoding and multiplexing protocol for the amplification and sequence-determination of class I HLA loci. We have coupled this process to a novel HLA calling algorithm to determine the most likely pair of alleles at each locus.
We have benchmarked our protocol with 270 HapMap individuals from four worldwide populations with 96.4% accuracy at 4-digit resolution. A variation of this initial protocol, more suitable for large sample sizes, in which molecular barcodes are added during PCR rather than library construction, was tested on 95 HapMap individuals with 98.6% accuracy at 4-digit resolution.
Next-generation sequencing on the 454 FLX Titanium platform is a reliable, efficient, and scalable technology for HLA typing.
The major histocompatibility complex (MHC) region on the short arm of chromosome 6 is one of the most complex regions in the human genome with extreme levels of polymorphism and linkage disequilibrium [1–3]. With a span of about 4 Mb, the MHC comprises many hundreds of genes . Of these, the human leukocyte antigen (HLA) genes are the most prominently studied. The HLA genes encode cell-surface proteins responsible for antigen peptide presentation in a cell-mediated immune response. Inherited DNA sequence variation within these genes is strongly associated with autoimmune and infectious diseases as well as severe adverse drug reactions [5–8]. Clinically, HLA sequence information is also widely used for matching donor and recipient in transplantation on the basis that more similar alleles will reduce the risk of rejection .
To date, 2048 unique 4-digit HLA alleles have been described in the IMGT/HLA database at class I, and 751 at class II . Over many years, best practices in HLA typing have traditionally been disseminated by the participants of the International Histocompatibility Workshop. Established methods include sequence specific oligonucleotide (SSO) hybridization and, more recently, capillary sequencing (Sanger method). SSO hybridization uses oligonucleotide probes to detect the presence (or absence) of polymorphisms specific to each probe. The Sanger method uses chain-termination fluorescence for DNA base-pair detection and sequencing.
Although these methods have proven effective for HLA typing, they remain labor-intensive, time-consuming and expensive. Further, one specific disadvantage of Sanger sequencing is that it does not generate two separate, haploid sequences, making it in some cases challenging to resolve the individual HLA haplotype sequences in a diploid pair of chromosome 6. The advent of next-generation sequencing technologies motivated us to develop an efficient protocol for genotyping of the classical HLA genes of class I.
The first method, termed "library construction-based barcoding," involves the addition of a molecular barcode to the standard 454 "A" adapter, which is ligated to double-stranded exon-specific amplicons during library construction. The exon-specific amplicons are pooled by sample (six products per pool) after PCR, and up to 96 samples are pooled after barcoded adapter ligation (Additional File 1).
The second method, termed "PCR-based barcoding" involves the addition of a barcode to the forward and reverse exon-specific PCR primers. The same unique barcode is added to all 6 exon-specific primer pairs (exons 2 and 3 of HLA-A, -B and -C) for a given sample. 95 different barcoded primer sets were designed in total, leaving an empty 96th well as a positional key (Additional File 1). Post-PCR all amplicons from all 95 samples are pooled and the pool proceeds through standard library construction with the addition of a non-barcoded adapter.
Both methods facilitate sample multiplexing prior to emulsion PCR and sequencing, which dramatically reduces the overall cost per individual for an all-in cost of less than $40 per sample for typing of Class I genes HLA-A, -B and -C. Using these methods a single technician can process up to 96 samples at once, creating a sequence-ready library in under three days. Because we are using the FLX Titanium chemistry, sequence reads extend across entire exons of the HLA genes (~350 base pairs).
The HLA calling algorithm determines the most likely pair of HLA types at each locus by systematically evaluating all possible pairs of 4-digit HLA types. We use three key components to calculate the posterior probability for each HLA allele pair. First, we compare genotypes for each allele pair to the genotypes determined by the Genome Analysis Toolkit (GATK) based on sequence data. Second, we check the allelic phase of each HLA allele pair for consistency with the sequence data. Specifically, we calculate the binomial probability that the phase orientation for a specific HLA allele pair is consistent with the sequence data at a pair of adjacent polymorphic sites, and aggregate these probabilities across all pairs of polymorphic sites. Third, we use information about the expected allele frequency to determine the prior probability of observing each pair of HLA alleles in the population (if the ancestry is known). We then multiply the probabilities calculated from base genotypes, allelic phase information, and allele frequencies, rescale (to ensure all posteriors sum to 1), and output the posterior probability for each HLA allele pair. The pair with the highest posterior probability corresponds to the best-guess genotype for that DNA sample.
In this study, we benchmark our protocol on DNA samples used in the International HapMap Project with known HLA types: 270 samples for library construction-based barcoding and 95 samples for the barcoded PCR method. We limited the sample number in our validation test of the barcoded PCR method to 95 due to the similarities to the already tested library-construction based method, and the number of barcoded primers arrayed per plate (i.e. 95 barcodes plus 1 empty well). We demonstrate that we can generate reliable HLA calls, and in some cases improve upon the existing calls, but also highlight instances of problematic alleles where calls are less robust in our current protocol. Overall, our protocol offers comparable data quality but outperforms traditional Sanger sequencing in terms of cost-effectiveness and throughput.
Distribution of HapMap samples by population and plate sequenced
Depth of coverage per individual across loci and plate pools
Plate 1 Coverage
Plate 2 Coverage
Plate 3 Coverage
Average coverage per locus
159 ± 87
65 ± 37
91 ± 60
106 ± 76
144 ± 61
71 ± 36
101 ± 52
106 ± 59
177 ± 74
89 ± 50
105 ± 56
125 ± 73
159 ± 72
93 ± 45
111 ± 54
121 ± 65
85 ± 44
62 ± 44
81 ± 66
76 ± 52
102 ± 50
70 ± 36
84 ± 50
85 ± 47
Average coverage per plate
137 ± 74
75 ± 43
95 ± 58
103 ± 65
HLA calling accuracy and concordance with gold standard in 270 individuals
Original type missing
Original type incorrect
Incorrect call due to low coverage
Incorrect due to other reasons
(= 90 × 6)
(= 90 × 6)
(= 45 × 6)
(= 45 × 6)
HLA alleles originally mistyped in the gold standard dataset
HLA typing accuracy across class I loci in 270 HapMap individuals using the library construction method
HLA alleles mistyped in 454 sequencing due to low or unbalanced coverage
# Correct calls
In the PCR-based barcoding method, 95 individuals were sequenced and typed, with a typing accuracy of 98.6% at 4-digit resolution and 99.6% at 2-digit resolution after adjusting for errors in the gold standard (Additional File 9). The improved typing accuracy resulted from reducing uneven coverage of specific HLA alleles. C*04:01, the genotype with the poorest coverage in the original method, was typed correctly in all 28 individuals with that genotype using this method. Likewise, A*30:01 was typed correctly in all 9 individuals with the genotype, highlighting the reduction of errors due to low coverage using this method.
We have developed two sample preparation methods and a systematic algorithm for class I HLA typing using next-generation sequencing. These methods leverage the longer read lengths and clonal amplification inherent to the 454 sequencing technology with the Titanium chemistry. Longer reads (>300 bp) capture critical phase information of nearby DNA variants, and enable accurate sequence alignment to the polymorphic HLA region. This information enables differentiation between highly similar alleles and is an important advantage over capillary-based methods.
The ability to capture DNA sequences with high depth of coverage and with phase information enabled us to confidently detect and correct errors in the gold standard database, originally typed using SSO hybridization. The high depth of coverage of 454 sequences minimizes genotyping errors, and the long read lengths and use of locus-specific primer sequences together help prevent alignment errors. Compared to SSO hybridization, 454 holds two main advantages: first, 454 generates many DNA reads for each chromosome while SSO generates only one intensity-based read, allowing 454 to correct for sequencing errors while SSO cannot. Second, reads from 454 sequencing contain phase information that can be used to resolve ambiguous allele combinations while SSO reads cannot. These advantages allowed us to confidently correct errors in the SSO based gold standard, and corrections were verified the laboratory that performed the original SSO experiments.
Related methods for performing HLA typing using 454 sequencing were recently developed by Gabriel et al., Lank et al. and Bentley et al. [16–18]. All of these methods employ a PCR primer modified with both barcode and adaptor sequences [16–18], resulting in significantly more expensive primers (requiring HPLC cleanup) for DNA library amplification than those in our method. In addition, we multiplex 95-96 barcoded samples into a single lane of an 8-region PicoTiter Plate (PTP), allowing for a maximum of 760 samples per run compared to 24 - 48 samples per run in the method by Bentley et al . The current estimate for minimum coverage required for accurate HLA typing by our HLA caller is 20 reads, whereas our samples received on average >100 reads per exon. This leaves open the possibility of sequencing additional amplicons per sample, or multiplexing more samples per sequencing run in future if necessary. The longer read lengths provided by the FLX Titanium technology also permit more flexibility in primer selection than the FLX technology used in the Bentley et al study. See Additional File 10 for a comprehensive comparison of these methods to ours.
While sequencing HLA exons 2 and 3 is not sufficient for distinguishing between all known HLA genotypes, it provides an extraordinary amount of identifying information, especially when combined with allele frequency information. Using the HLA database, Lank et al. (2010) predict that exons 2, 3, and 4 theoretically differentiate 85% of all known alleles, however this figure likely underestimates the true typing capacity since they did not considering the effect of allele frequency on the incidence of uniquely identifiable alleles. We were able to achieve 96.4% to 98.6% empirical 4-digit typing accuracy by sequencing only exons 2 and 3, in addition to using frequency information to differentiate between ambiguous HLA genotypes. Without frequency information, it is difficult to identify the true HLA types, but it is possible to generate a short list (average 3 to 6) of candidate HLA allele pairs from a total of 34,584 possibilities at HLA-A, 143,648 at HLA-B, and 48,672 at HLA-C. The true allele pair may be differentiated from the other candidates by having the highest multiplicative frequency in the vast majority of cases. In the rare instance that the HLA genotype remains ambiguous after using frequency information, a list of top candidate alleles may be provided. Additional exons may be sequenced if high-resolution HLA types are desired, for to type individuals in rare populations or for to discover new HLA alleles.
One concern is that the incorporation of population frequency information may bias the HLA typing for a few specific HLA alleles. The definitive solution for preventing report bias is to sequence the entire HLA gene to remove all ambiguities in the genotype background. However this approach is not yet cost effective for most technologies and may hinder multiplexing throughput and efficiency. The interim solution is to report all alleles that match the particular genotype background (nucleotide sequence) and phase, with a pair of alleles that are designated to be the most likely given the expected frequency in the population in question. Another concern may be the accuracy of allele frequencies. All frequency information was collected from http://www.allelefrequencies.net, a central resource that has aggregated HLA type frequencies from hundreds of sources including blood banks, research facilities, and other studies . To our knowledge, this is the most reliable source of HLA (and KIR) allele frequencies available. The problem of allele skew is common to all HLA typing methods that do not sequence the entire gene, however report bias may be prevented by reporting all matching alleles in addition to the most likely alleles with frequency information.
Our sequencing methods may be modified to accommodate additional amplicons at the HLA loci (i.e. class I exon 4, or exons in HLA class II). Because the average depth of coverage in the current method (> 100 reads per site) exceeds the estimated coverage required for accurate typing (10-20 reads), the addition of a small number of additional amplicons (i.e. exon 4 of HLA-A, -B, and/or -C) may work in the current multiplexing protocol. Efforts are also underway to develop class II HLA typing capacity. However, the addition of a significant number of amplicons (1 to 2 for each of HLA-DRB1, -DQA, -DQB, -DPA, -DPB) may require decreasing the multiplexing rate by about ½ to maintain a similar depth of coverage. However such changes are well compensated by the high efficiency of sample multiplexing and cost savings from pre-barcoded primers. The main challenge in class II is to design primers that target specific class II HLA genes instead of others in the same homologous family (HLA-DRB1, -DRB2, - DRB3, etc).
We have described two sample preparation methods that differ in the pooling and barcoding strategies employed. Both methods represent facile approaches to amplification and HLA Class I genotyping. If large sample numbers (thousands) are to be processed the PCR-based barcoding method may be preferential as it facilitates pooling of all amplicons directly after PCR, meaning that only a single library construction is required downstream. These changes significantly cut the cost and increase the throughput of HLA typing. Using this process a single technician can amplify, pool and adapt up to 96 samples in two days. Class I HLA typing of samples prepared in this way costs less than $40 per sample, as calculated using our all-in, end-to-end internal accounting model.
Next-generation 454 sequencing is a reliable, efficient, and scalable technology for HLA typing. Important advantages of 454 over traditional sequencing technologies include its high depth of coverage and long read lengths to improve HLA typing accuracy, as well as its high multiplexing rate to maximize throughput while minimizing cost. We have developed novel laboratory methods to sequence the class I HLA loci using 454 technology, and a robust HLA caller algorithm to perform HLA typing using sequence genotype, allelic phase, and population-based frequency information. We have validated these laboratory and computational methods by typing HapMap individuals with high accuracy, and in some cases, provided corrections to the SSO-based gold standard database after systematic review and validation
A set of 270 samples were selected from the original HapMap collection, and consisted of 90 Yoruban, 90 European, 45 Chinese and 45 Japanese individuals (Table 1). These samples were previously sequenced via SSO hybridization .
Six HLA Class I exonic regions were amplified by PCR: exons 2 and 3 in each of HLA-A, -B, and -C. Primers were designed to fall within the intronic regions surrounding the exon of interest (Figure 1, Additional File 11). Each primer pair was designed to uniquely target a specific HLA locus without promiscuity. Degenerate bases were included in primers to accommodate the known sequence diversity, as described in the international ImMunoGeneTics IMGT/HLA database (http://www.ebi.ac.uk/imgt/hla/) [10, 20]. Primer sequences and locations are described in Additional File 11. Several resources were used for primer design: MUSCLE (http://www.ebi.ac.uk/Tools/muscle/) was used for multiple alignment, Jalview (http://www.jalview.org/) was used for alignment visualization, Primer3 (v 0.4.0, http://frodo.wi.mit.edu/primer3/) was used for primer sequence design, and In-Silico PCR (http://genome.ucsc.edu/cgi-bin/hgPcr?command=start) was used to ensure that each primer pair would amplify only a single region in the human genome [10, 20–24].
PCR amplification and Pooling
Library construction-based barcoding method
Six PCR amplifications were performed for each sample; one for each of the six exons of interest. Reaction setup was performed on the Bravo Liquid Handling Platform (Agilent Technologies, Santa Clara, CA). Briefly, 20 ul reaction volumes consisted of 1× Platinum Taq buffer (Invitrogen, Carlsbad, CA), 10 mM dNTPs, 50 mM MgSO4, 10 mg/ml BSA, 0.5% DMSO, 1 uM of each primer, 0.2 ul Platinum Taq (Invitrogen, Carlsbad, CA), with 100 ng genomic DNA. Thermal cycling conditions were: 3 mins at 95°C, 15 secs at 95°C × 5 cycles, 15 secs at 62°C, 60 secs at 72°C, 15 secs at 95°C × 26 cycles, 15 secs at 58°C, 60 secs at 72°C, 15 secs at 95°C × 4 cycles, 60 secs at 55°C, 2 mins at 72°C, and 7 mins at 72°C. PCR product sizes were confirmed on 2% eGels (Invitrogen, Carlsbad, CA) and, after 1:1 dilution of the PCR product in water, concentrations were determined using the Quant-it PicoGreen dsDNA Kit (Invitrogen, Carlsbad, CA). PCR products from the six amplicons for a given patient were normalized by concentration before being pooled together prior to library construction. Pooled, normalized PCR reactions were purified using 1.5× the PCR reaction volume of Agencourt AMPure XP beads (Beckman Coulter, Brea, CA).
Six amplifications per sample were set up as described above with the only difference being that each primer pair for a given patient sample was tailed with a specific barcode tag sequence. Amplified products were normalized by concentration and all amplicons for every patient were pooled into a single receptacle. Pooled products were purified and concentrated using Qiagen's Minelute kit (Qiagen, Hilden, Germany) prior to library construction.
Library Construction and 454 sequencing
Our library construction protocol was slightly modified from the GS FLX Titanium General Library Preparation Manual (October 2008)  to include process automation using the Bravo Liquid Handling Platform  (Additional File 1). Briefly, amplicons were made blunt-ended and phosphorylated using T4 polymerase (NEB, Ipswich, MA) and Polynucleotide Kinase (NEB, Ipswich, MA). 454 amplification and sequencing adaptors were then ligated to the resulting blunt-ends. To facilitate sample pooling for the library construction-based method, we designed a set of 120 modified adaptors, with each adaptor having a unique sequence tag immediately following the adaptor key sequence ( for more details). After adaptor ligation, ligase was heat inactivated at 65°C for 10 minutes, and samples were pooled by volume into a single tube. Each pool was concentrated and cleaned using a MinElute Reaction Cleanup Kit (Qiagen, Germany) and Ampure XP beads, (Beckman Coulter Genomics, Beverley, MA), prior to standard bead immobilization and strand-melting (GS FLX Titanium General Library Preparation Manual, October 2008). Adapted, single-stranded library pools were then quantified by qPCR, prior to emulsion PCR amplification and sequencing on a 454 Genome Sequencer FLX instrument (Additional File 1). For the 270 HapMap samples prepared using library construction-based barcoding, a total of three library pools were created, with 96 samples in each of the first two pools, and 78 in the third. All sequence data associated with this project has been submitted to NCBI's Short Reads Archive (SRA database, under accession number SRP003652.
454 read processing and alignment
DNA sequence reads for each pool were obtained in binary SFF format, and converted to FASTA/FASTQ format using the software SSFINFO (Roche). Reads for each individual were parsed using uniquely identifying 6-9 base-pair molecular barcodes. For each individual, reads corresponding to specific HLA loci were identified using the 18-21 base-pair primer sequences. Parsed reads were then aligned locally to the reference sequence at HLA-A, HLA-B, or HLA-C using SSAHA2 (http://www.sanger.ac.uk/resources/software/ssaha2/) and output in SAM/BAM format [alignment parameters included: word hash size = 8, step size = 3, tolerated difference from reference = 10]. Misalignments were detected algorithmically by comparing aligned reads to the dictionary of known HLA alleles at each locus (IMGT/HLA database). Reads identified with having < 75% SNP homology with the closest matching allele were removed. After misalignment removal, the average depth of coverage was calculated for each individual at each of the six exons amplified.
HLA sequence dictionary and allele frequencies
DNA sequences for all HLA alleles were obtained from the IMGT/HLA database (http://www.ebi.ac.uk/imgt/hla/) version 2.26. Four-digit HLA genotype frequencies were obtained from http://www.allelefrequencies.net for "Caucasoid," "Black," and "Asian" populations. A weighted average of allele frequencies was calculated for each population using the numerous available sources available from this central repository for each population. The latest HLA nomenclature [27, 28] was adopted for all typing purposes.
Classical HLA genotype assignment
The HLA calling algorithm was developed using Java as part of the open-source Genome Analysis Tool Kit (GATK) . The GATK can be found at http://www.broadinstitute.org/gsa/wiki/index.php/The_Genome_Analysis_Toolkit.
We use the HLA calling algorithm (Figure 2) to examine next generation sequencing data to determine the most likely HLA genotypes at each locus. Using this tool, we systematically evaluate all possible pairs of 4-digit HLA alleles and calculate the posterior probability for each allele pair based on three key considerations: 1) the genotypes at each base position observed across reads, 2) the phase information of neighbouring variants observed on individual reads, and 3) the frequency of different alleles at each locus. After calculating probabilities based on each of these key considerations, we multiply the scores to determine the overall posterior probability that an HLA allele pair is the true genotype.
We first use the GATK to determine the probability of observing each base genotype at every position in the HLA loci given the 454 sequence reads. The GATK automatically incorporates base and alignment quality scores when calculating these probabilities. For a pair of HLA alleles, we then iterate through each base position and multiply the probabilities of observing the base genotypes unique to these HLA alleles given the 454 sequence reads as previously calculated by the GATK (Figure 2, panel A). This is repeated for each HLA allele pair at every locus to determine P genotype .
We then use a phasing algorithm to examine each pair of adjacent polymorphic sites and, using a binomial distribution, calculate the probability that the phase orientation for a specific HLA allele pair is consistent with the sequence data at those sites (Figure 2, panel B). This probability is calculated by counting the number of sequence reads that match the allelic phase of the HLA allele pair in question compared to the total number of reads, and a binomial probability is determined using an estimated sequencing error rate (P err ) of 1%. This probability is then aggregated multiplicatively across all adjacent polymorphic sites for each HLA allele pair, and is termed P phase .
We then calculate the probability of observing each pair of HLA alleles in the population by multiplying the two allele frequencies of interest (Figure 2, panel C). This probability was termed P frequency . We used allele frequencies corresponding to the White, Black, and Asian populations obtained from http://www.allelefrequencies.net.
Finally, we combine the three scores by multiplying P genotypes , P phase , and P frequency to determine the overall posterior probability, P combined , that a particular allele pair is the true type. We normalized these probabilities to ensure that the probabilities for each locus sum to 1. We report all allele pairs that match the particular genotype background and phase (i.e. that have the highest P genotypes × P phase ), and designate a pair of alleles that are as the most likely given the addition of frequency information (i.e. that has the highest P combined ). These alleles are assigned as the final HLA calls.
We determined two- and four-digit typing accuracy by comparing HLA calls to the gold standard types. All non-concordant calls were manually inspected using the Integrative Genomics Viewer (IGV, http://www.broadinstitute.org/igv/) to identify the possible reasons for discordance. Incorrect calls in the gold standard data were reported to the original typing laboratory, and were validated using Sanger sequencing.
The generated sequence data and HLA calls are available from the Resources section at: http://debakker.med.harvard.edu/
This project has been funded [in part] through the Collaboration for AIDS Vaccine Discovery with support from the Bill & Melinda Gates Foundation (MRH & PIWDB). This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract HHSN26120080001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. This Research was supported [in part] by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research.
- Consortium: Complete sequence and gene map of a human major histocompatibility complex. The MHC sequencing consortium. Nature. 1999, 401: 921-923. 10.1038/44853.View Article
- de Bakker PI, McVean G, Sabeti PC, Miretti MM, Green T, Marchini J, Ke X, Monsuur AJ, Whittaker P, Delgado M, et al: A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nature genetics. 2006, 38: 1166-1172. 10.1038/ng1885.PubMed CentralPubMedView Article
- Horton R, Gibson R, Coggill P, Miretti M, Allcock RJ, Almeida J, Forbes S, Gilbert JG, Halls K, Harrow JL, et al: Variation analysis and gene annotation of eight MHC haplotypes: the MHC Haplotype Project. Immunogenetics. 2008, 60: 1-18. 10.1007/s00251-007-0262-2.PubMed CentralPubMedView Article
- Horton R, Wilming L, Rand V, Lovering RC, Bruford EA, Khodiyar VK, Lush MJ, Povey S, Talbot CC, Wright MW, et al: Gene map of the extended human MHC. Nat Rev Genet. 2004, 5: 889-899. 10.1038/nrg1489.PubMedView Article
- Carrington M, O'Brien SJ: The influence of HLA genotype on AIDS. Annu Rev Med. 2003, 54: 535-551. 10.1146/annurev.med.54.101601.152346.PubMedView Article
- Fernando MM, Stevens CR, Walsh EC, De Jager PL, Goyette P, Plenge RM, Vyse TJ, Rioux JD: Defining the role of the MHC in autoimmunity: a review and pooled analysis. PLoS Genet. 2008, 4: e1000024-10.1371/journal.pgen.1000024.PubMed CentralPubMedView Article
- Rioux JD, Goyette P, Vyse TJ, Hammarstrom L, Fernando MM, Green T, De Jager PL, Foisy S, Wang J, de Bakker PI, et al: Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases. Proc Natl Acad Sci USA. 2009, 106: 18680-18685. 10.1073/pnas.0909307106.PubMed CentralPubMedView Article
- Ryder LP, Svejgaard A, Dausset J: Genetics of HLA disease association. Annu Rev Genet. 1981, 15: 169-187. 10.1146/annurev.ge.15.120181.001125.PubMedView Article
- Morishima Y, Sasazuki T, Inoko H, Juji T, Akaza T, Yamamoto K, Ishikawa Y, Kato S, Sao H, Sakamaki H, et al: The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors. Blood. 2002, 99: 4200-4206. 10.1182/blood.V99.11.4200.PubMedView Article
- Robinson J, Waller MJ, Fail SC, McWilliam H, Lopez R, Parham P, Marsh SG: The IMGT/HLA database. Nucleic acids research. 2009, 37: D1013-1017. 10.1093/nar/gkn662.PubMed CentralPubMedView Article
- Hansen JA, (Ed): Immunobiology of the Human MHC. Proceedings of the 13th International Histocompatibility Workshop and Conference. 2002
- Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R: The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009, Oxford, England, 25: 2078-2079. 10.1093/bioinformatics/btp352.
- McKenna AH, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly M, Depristo M: The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data. Genome research. 2010, 20: 1297-1303. 10.1101/gr.107524.110.PubMed CentralPubMedView Article
- Marsh SG: Nomenclature for factors of the HLA system, update May 2006. Tissue antigens. 2006, 68: 273-275. 10.1111/j.1399-0039.2006.00660.x.PubMedView Article
- Marsh SG: Nomenclature for factors of the HLA system, update March 2005. Hum Immunol. 2005, 66: 1017-1018. 10.1016/j.humimm.2005.10.014.PubMedView Article
- Bentley G, Higuchi R, Hoglund B, Goodridge D, Sayer D, Trachtenberg EA, Erlich HA: High-resolution, high-throughput HLA genotyping by next-generation sequencing. Tissue antigens. 2009, 74: 393-403. 10.1111/j.1399-0039.2009.01345.x.PubMed CentralPubMedView Article
- Lank SM, Wiseman RW, Dudley DM, O'Connor DH: A novel single cDNA amplicon pyrosequencing method for high-throughput, cost-effective sequence-based HLA class-I genotyping. Hum Immunol. 2010, 71: 1011-1017. 10.1016/j.humimm.2010.07.012.PubMed CentralPubMedView Article
- Gabriel C, Danzer M, Hackl C, Kopal G, Hufnagl P, Hofer K, Polin H, Stabentheiner S, Proll J: Rapid high-throughput human leukocyte antigen typing by massively parallel pyrosequencing for high-resolution allele identification. Hum Immunol. 2009, 70: 960-964. 10.1016/j.humimm.2009.08.009.PubMedView Article
- Middleton D, Menchaca L, Rood H, Komerofsky R: New allele frequency database. Tissue antigens. 2003, 61: 403-407. 10.1034/j.1399-0039.2003.00062.x. [http://www.allelefrequencies.net]PubMedView Article
- Robinson J, Waller MJ, Parham P, de Groot N, Bontrop R, Kennedy LJ, Stoehr P, Marsh SG: IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex. Nucleic acids research. 2003, 31: 311-314. 10.1093/nar/gkg070.PubMed CentralPubMedView Article
- Edgar RC: MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic acids research. 2004, 32: 1792-1797. 10.1093/nar/gkh340.PubMed CentralPubMedView Article
- Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, Haussler D: The human genome browser at UCSC. Genome research. 2002, 12: 996-1006.PubMed CentralPubMedView Article
- Rozen S, Skaletsky H: Primer3 on the WWW for general users and for biologist programmers. Methods in molecular biology (Clifton, NJ. 2000, 132: 365-386.
- Waterhouse AM, Procter JB, Martin DM, Clamp M, Barton GJ: Jalview Version 2--a multiple sequence alignment editor and analysis workbench. Bioinformatics. 2009, Oxford, England, 25: 1189-1191. 10.1093/bioinformatics/btp033.
- Margulies M, Egholm M, Altman WE, Attiya S, Bader JS, Bemben LA, Berka J, Braverman MS, Chen YJ, Chen Z, et al: Genome sequencing in microfabricated high-density picolitre reactors. Nature. 2005, 437: 376-380.PubMed CentralPubMed
- Lennon NJ, Lintner RE, Anderson S, Alvarez P, Barry A, Brockman W, Daza R, Erlich RL, Giannoukos G, Green L, et al: A scalable, fully automated process for construction of sequence-ready barcoded libraries for 454. Genome biology. 2010, 11: R15-10.1186/gb-2010-11-2-r15.PubMed CentralPubMedView Article
- Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Fernandez-Vina M, Geraghty DE, Holdsworth R, Hurley CK, et al: Nomenclature for factors of the HLA system, 2010. Tissue antigens. 2010, 75: 291-455. 10.1111/j.1399-0039.2010.01466.x.PubMed CentralPubMedView Article
- Marsh SG: Nomenclature for factors of the HLA system, update February 2010. Tissue antigens. 2010, 76: 165-170.PubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.